Skip to main content
Log in

Preparation and In Vitro/In Vivo Evaluation of Antihistaminic Ocular Inserts

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The present study aims to prepare ocular inserts of cetirizine hydrochloride, an antihistamine used to treat allergic conjunctivitis, allergic rhinitis, uveitis and urticaria. Solvent casting method was used to prepare inserts of hydroxypropyl methylcellulose (HPMC) and polyvinyl alcohol (PVA) as film forming polymers, and polyethylene glycol (PG) and glycerin were used as plasticizers. Various physicochemical parameters of six ocular insert compositions were evaluated, including swelling behavior and in vitro drug release and kinetics. Formulation F4 showed results of in vitro studies in most appropriate range, with sustained drug release (99.12% at 210 min) following non-fickian diffusion. Drug – polymer compatibility study verified no chemical interaction between the drug and polymer. Therefore, formulation F4 was selected for in vivo studies in albino rabbits. The values of Cmax, AUC, and Tmax of formulation F4 were 478.70 ng/mL, 3013.58 ng/(mL h), and 2.3 h, respectively. Ocular inserts of cetirizine hydrochloride provide a valuable alternative for the treatment of ocular inflammatory diseases as these formulations ensure sustained drug release and increased residence time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. M. H. Aburahma and A. A. Mahmoud, AAPS PharmSciTech, 12, 1334 – 1347 (2011).

    Article  Google Scholar 

  2. K. P. S. Kumar, D. Bhowmik, G. Harish, et al., The Pharma Innovation., 1 (2013)

  3. S. El-Sousi, A. Nacher, C. Mura, et al., J. Pharm. Pharmacol., 65, 193 – 200 (2012).

    Article  Google Scholar 

  4. A. Kumari, P. K. Sharma, K. Vipin, et al., J. Adv. Pharm. Technol. Res., 1, 291 – 296 (2010).

    Article  CAS  Google Scholar 

  5. N. L. Eremeev, V. N. Ermakova, O. A. Kost, et al., Pharm. Chem. J., 40, 36 – 39 (2006).

    Article  CAS  Google Scholar 

  6. S. Ramkanth, C. M. Chetty, M. Alagusundaram, et al., Int. J. Pharm. Tech. Res., 1, 1219 – 1223 (2009).

    CAS  Google Scholar 

  7. M. K. Arýcý, D. S. Arýcý, A. Topalkara, et al., Clin. Exp. Ophthalmol., 28, 113 – 117 (2000).

    Article  Google Scholar 

  8. A. Zimmer and J. Kreuter, Adv. Drug Deliv. Rev., 16, 61 – 73 (1995).

    Article  CAS  Google Scholar 

  9. A. Durrani, S. Farr, and I. Kellaway, J. Pharm. Pharmacol., 47, 581 – 584 (1995).

    Article  CAS  Google Scholar 

  10. I. Genta, B. Conti, P. Perugini, et al., J. Pharm. Pharmacol., 49, 737 – 742 (1997).

    Article  CAS  Google Scholar 

  11. P. Giunchedi, U. Conte, P. Chetoni, et al., Eur. J. Pharm. Sci., 9, 1 – 7 (1999).

    Article  CAS  Google Scholar 

  12. S. F. Bernatchez, A. Merkli, T. L. Minh, et al., J. Biomed. Mater. Res., 28, 1037 – 1046 (1994).

    Article  CAS  Google Scholar 

  13. R. Gurny, T. Boye, and H. Ibrahim, J. Control. Release, 2, 353 – 361 (1985).

    Article  CAS  Google Scholar 

  14. K. Langer, A. Zimmer, and J. Kreuter, STP Pharma. Sci., 7, 445 – 451 (1997).

    CAS  Google Scholar 

  15. M. S. Nagarsenker, V. Y. Londhe, and G. D. Nadkarni, Int. J. Pharm., 190, 63 – 71 (1999).

    Article  CAS  Google Scholar 

  16. S. L. Law, K. J. Huang, and C. H. Chiang, J. Control. Release, 63, 135 – 140 (2000).

    Article  CAS  Google Scholar 

  17. E. Bertelmann, T. Ritter, K. Vogt, et al., Ophthalmic Res., 35, 117 – 124 (2003).

    Article  CAS  Google Scholar 

  18. F. Gurtler and R. Gurny, Drug Dev. Ind. Pharm., 21, 1 – 18 (1995).

    Article  CAS  Google Scholar 

  19. M. F. Saettone and L. Salminen, Adv. Drug Deliv. Rev., 16, 95 – 106 (1995).

    Article  CAS  Google Scholar 

  20. F. Gurtler, V. Kaltsatos, B. Boisrame, et al., J. Control. Release., 33, 231 – 236 (1995).

    Article  CAS  Google Scholar 

  21. J. G. Souza, K. Dias, T. A. Pereira, et al., J. Pharm. Pharmacol., 66, 507 – 530 (2013).

    Article  Google Scholar 

  22. M. J. Alonso and A. Sanchez, J. Pharm. Pharmacol., 55, 1451 – 1463 (2003).

    Article  CAS  Google Scholar 

  23. Y. C. Lee, J. W. Millard, G. J. Negvesky, et al., Int. J. Pharm., 182, 121 – 126 (1999).

    Article  CAS  Google Scholar 

  24. S. Kawakami, K. Nishida, T. Mukai, et al., J. Control. Release, 76, 255 – 263 (2001).

    Article  CAS  Google Scholar 

  25. J. Ceulemans, A. Vermeire, E. Adriaens, et al., J. Control. Release, 77, 333 – 344 (2001).

    Article  CAS  Google Scholar 

  26. P. Pawar, R. Katara, and D. Majumdar, Acta Pharm., 62, 93 – 104 (2012).

    Article  CAS  Google Scholar 

  27. J. Balasubramaniam, A. Srinatha, G. Nath, et al., Indian J. Pharm. Sci., 68, 626 – 630 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors greatly appreciate the moral support of our research group.

DECLARATIONS

Conflict of Interest

The authors declare that they have no conlicts of interest to disclose.

Funding

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad Akhtar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shah, S.N.H., Nawaz, A., Javed, H. et al. Preparation and In Vitro/In Vivo Evaluation of Antihistaminic Ocular Inserts. Pharm Chem J 52, 615–622 (2018). https://doi.org/10.1007/s11094-018-1870-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1870-x

Keywords

Navigation